These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19451652)

  • 1. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.
    Ghosh A; Kuppusamy H; Pilarski LM
    J Biol Chem; 2009 Jul; 284(28):18840-50. PubMed ID: 19451652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
    Kriangkum J; Warkentin A; Belch AR; Pilarski LM
    PLoS One; 2013; 8(1):e53469. PubMed ID: 23301075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
    Adamia S; Kriangkum J; Belch AR; Pilarski LM
    Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
    Adamia S; Reiman T; Crainie M; Mant MJ; Belch AR; Pilarski LM
    Blood; 2005 Jun; 105(12):4836-44. PubMed ID: 15731173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets.
    Adamia S; Pilarski PM; Belch AR; Pilarski LM
    Curr Cancer Drug Targets; 2013 May; 13(4):347-61. PubMed ID: 23517594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia.
    Adamia S; Treon SP; Reiman T; Tournilhac O; McQuarrie C; Mant MJ; Belch AR; Pilarski LM
    Clin Lymphoma; 2005 Mar; 5(4):253-6. PubMed ID: 15794859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.
    Kuppusamy H; Ogmundsdottir HM; Baigorri E; Warkentin A; Steingrimsdottir H; Haraldsdottir V; Mant MJ; Mackey J; Johnston JB; Adamia S; Belch AR; Pilarski LM
    PLoS One; 2014; 9(6):e100691. PubMed ID: 24950197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
    Adamia S; Reichert AA; Kuppusamy H; Kriangkum J; Ghosh A; Hodges JJ; Pilarski PM; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Blood; 2008 Dec; 112(13):5111-21. PubMed ID: 18815290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence resonance energy transfer (FRET) and proximity ligation assays reveal functionally relevant homo- and heteromeric complexes among hyaluronan synthases HAS1, HAS2, and HAS3.
    Bart G; Vico NO; Hassinen A; Pujol FM; Deen AJ; Ruusala A; Tammi RH; Squire A; Heldin P; Kellokumpu S; Tammi MI
    J Biol Chem; 2015 May; 290(18):11479-90. PubMed ID: 25795779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity.
    Yoshida M; Itano N; Yamada Y; Kimata K
    J Biol Chem; 2000 Jan; 275(1):497-506. PubMed ID: 10617644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation.
    Itano N; Sawai T; Atsumi F; Miyaishi O; Taniguchi S; Kannagi R; Hamaguchi M; Kimata K
    J Biol Chem; 2004 Apr; 279(18):18679-87. PubMed ID: 14724275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3.
    Mack JA; Feldman RJ; Itano N; Kimata K; Lauer M; Hascall VC; Maytin EV
    J Invest Dermatol; 2012 Jan; 132(1):198-207. PubMed ID: 21850020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
    Nykopp TK; Rilla K; Sironen R; Tammi MI; Tammi RH; Hämäläinen K; Heikkinen AM; Komulainen M; Kosma VM; Anttila M
    BMC Cancer; 2009 May; 9():143. PubMed ID: 19435493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hyaluronan synthase 1 and distribution of hyaluronan during follicular atresia in pig ovaries.
    Miyake Y; Sakurai M; Tanaka S; Tunjung WA; Yokoo M; Matsumoto H; Aso H; Yamaguchi T; Sato E
    Biol Reprod; 2009 Feb; 80(2):249-57. PubMed ID: 18923162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAS1 expression in bladder cancer and its relation to urinary HA test.
    Golshani R; Hautmann SH; Estrella V; Cohen BL; Kyle CC; Manoharan M; Jorda M; Soloway MS; Lokeshwar VB
    Int J Cancer; 2007 Apr; 120(8):1712-20. PubMed ID: 17230515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide.
    Stuhlmeier KM
    J Immunol; 2005 Jun; 174(11):7376-82. PubMed ID: 15905585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients.
    Calabro A; Oken MM; Hascall VC; Masellis AM
    Blood; 2002 Oct; 100(7):2578-85. PubMed ID: 12239172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation.
    Chao H; Spicer AP
    J Biol Chem; 2005 Jul; 280(30):27513-22. PubMed ID: 15843373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.
    Zhang L; Bowen T; Grennan-Jones F; Paddon C; Giles P; Webber J; Steadman R; Ludgate M
    J Biol Chem; 2009 Sep; 284(39):26447-55. PubMed ID: 19633293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.